Tardive dyskinesia, a side effect of antipsychotic medications, causes involuntary muscle movements. Learn about its symptoms, causes, and treatment.

While tardive dyskinesia can be distressing, there are treatments available to help manage the symptoms. In some cases, reducing or changing the offending medication can make a significant difference.

Even though the term tardive dyskinesia was coined about 60 years ago, an "umbrella" term—tardive syndrome—has been gaining acceptance in medical circles. The terms have often been used ...

Spotlight On > Tardive Dyskinesia Treatment of Tardive Dyskinesia — Until 2017, no FDA approved options existed for serious side effect of dopamine-blocking drugs by Kristen Monaco, Senior Staff ...

Tardive dyskinesia (TD) is a neurological disorder brought on by the long-term use of medications that block dopamine, such as antipsychotics. While treatable, TD can have significant physical and ...

The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation. J Patient Rep Outcomes. 2024;8 (1):2. doi:10. ...

"Tardive dyskinesia can affect patients' daily lives, causing pain and anxiety and hindering the ability to perform self-care tasks and to participate in work, family or social life," said Eiry W ...

Aggarwal S, Serbin M, Yonan C. Indirect treatment comparison of valbenazine and deutetrabenazine efficacy and safety in tardive dyskinesia. J Comp Eff Res. 2019;8 (13):1077-1088. doi:10.2217/cer ...

Neurocrine Biosciences Publishes Analysis Showing Long-Term Efficacy and a Consistent Safety Profile of INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia in The Journal of ...

Session ID: 2025-07-18:4f3fa8dc277d7b36a205158 Player Element ID: V96446f73_6736_47e5_a1b7_da8dad551ebf_6347209446112 ...

References: Neurocrine Biosciences announces US FDA accepts New Drug Application for Ingrezza® (valbenazine) oral granules sprinkle formulation. News release. Neurocrine Biosciences. September 14 ...